Yeon-Ah Lee
Overview
Explore the profile of Yeon-Ah Lee including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
61
Citations
921
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yeo J, Seo M, Park J, Lee Y, Lee J, Kang E, et al.
Korean J Intern Med
. 2024 May;
40(1):40-48.
PMID: 38798046
Axial spondyloarthritis (axSpA) is a chronic inflammatory disorder affecting the sacroiliac joints and axial spine. Along with pharmacotherapy, non-pharmacological interventions for axSpA are crucial and constitute the cornerstone of treatment....
2.
Jeong E, Hong H, Lee Y, Kim K
Int J Mol Sci
. 2024 Mar;
25(5).
PMID: 38473928
Rheumatoid arthritis (RA) is a systemic autoimmune disease characterized by swelling in at least one joint. Owing to an overactive immune response, extra-articular manifestations are observed in certain cases, with...
3.
Lee Y, Hong S, Lee G, Shin S, Hong J, Chung S, et al.
Sci Rep
. 2024 Feb;
14(1):4316.
PMID: 38383594
Rheumatoid arthritis (RA) and osteoarthritis (OA) are two different types of arthritis. Within RA, the subsets between seronegative RA (snRA) and seropositive RA (spRA) represent distinct disease entities; however, identifying...
4.
Seo M, Yeo J, Park J, Lee Y, Lee J, Kang E, et al.
J Rheum Dis
. 2024 Jan;
31(1):62-63.
PMID: 38164191
[This corrects the article on p. 151 in vol. 30, PMID: 37476674.].
5.
Seo M, Yeo J, Park J, Lee Y, Lee J, Kang E, et al.
Korean J Intern Med
. 2023 Nov;
39(1):200.
PMID: 37946452
No abstract available.
6.
Seo M, Yeo J, Park J, Lee Y, Lee J, Kang E, et al.
Korean J Intern Med
. 2023 Jul;
38(5):620-640.
PMID: 37482652
We aimed to develop evidence-based recommendations for treating axial spondylarthritis (axSpA) in Korea. The development committee was constructed, key clinical questions were determined, and the evidence was searched through online...
7.
Seo M, Yeo J, Park J, Lee Y, Lee J, Kang E, et al.
J Rheum Dis
. 2023 Jul;
30(3):151-169.
PMID: 37476674
We aimed to develop evidence-based recommendations for treating axial spondylarthritis (axSpA) in Korea. The development committee was constructed, key clinical questions were determined, and the evidence was searched through online...
8.
Cho S, Kim H, Song Y, Kim H, Nam E, Lee S, et al.
Korean J Intern Med
. 2023 Jun;
38(4):546-556.
PMID: 37334513
Background/aims: We aimed to compare the effectiveness and safety of Janus kinase inhibitors (JAKi) vs. biologic disease- modifying antirheumatic drugs (bDMARD) in Korean patients with rheumatoid arthritis (RA) who had...
9.
Chang S, Lee J, Ha Y, Kim M, Park C, Lee J, et al.
Rheumatology (Oxford)
. 2023 Jan;
62(9):3014-3024.
PMID: 36702465
Objectives: To explore the course of lung function and RA disease activity and predictive factors for deteriorating lung function in patients with RA-interstitial lung disease (ILD). Methods: The Korean Rheumatoid...
10.
Yoo W, Kang Y, Kim D, Kang E, Lee Y, Suh C, et al.
Rheumatol Ther
. 2022 Dec;
10(2):329-341.
PMID: 36482248
Introduction: SB4 is the first approved biosimilar of etanercept, a biologic tumor necrosis factor inhibitor, to treat various autoimmune diseases including axial spondylarthritis (axSpA), rheumatoid arthritis (RA), psoriatic arthritis (PsA),...